Innovex International (NYSE:INVX – Get Free Report) had its target price decreased by Barclays from $21.00 to $15.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has an “underweight” rating on the stock. Barclays‘s target price would indicate a potential downside of 8.06% from the company’s current price.
Innovex International Stock Performance
NYSE:INVX opened at $16.32 on Tuesday. Innovex International has a 52 week low of $13.80 and a 52 week high of $25.19. The company has a market capitalization of $1.10 billion, a P/E ratio of 11.51 and a beta of 0.85. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.17 and a current ratio of 3.87.
Innovex International Company Profile
Further Reading
- Five stocks we like better than Innovex International
- 3 Healthcare Dividend Stocks to Buy
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Stock Market Index and How Do You Use Them?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Innovex International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovex International and related companies with MarketBeat.com's FREE daily email newsletter.